Literature DB >> 10720558

Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania.

G Poggensee1, I Kiwelu, V Weger, D Göppner, T Diedrich, I Krantz, H Feldmeier.   

Abstract

Female genital schistosomiasis (FGS) is a neglected disease manifestation of schistosomiasis. A cross-sectional study was carried out to assess in a schistosomiasis-endemic area the proportion of women affected by FGS of the lower reproductive tract and to compare the frequency of symptoms and signs possibly associated with FGS between women with proven FGS (n=134), endemic referents (n=225, women living in an endemic site), and referents (n=75, women living in a nonendemic site). Urinary schistosomiasis was diagnosed in 36% (239/657) and FGS in 37% (134/359) of the women. Cervical lesions occurred in 75% of the FGS cases, in 48% of endemic referents, and in 36% of nonendemic referents. The high prevalence of FGS in all age groups and the high levels of pathologic cervical alterations such as swollen and disrupted epithelium support the hypothesis that FGS might be a risk factor for the transmission of human immunodeficiency virus.

Entities:  

Mesh:

Year:  2000        PMID: 10720558     DOI: 10.1086/315345

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region.

Authors:  Jennifer A Downs; Charles Mguta; Godfrey M Kaatano; Katrina B Mitchell; Heejung Bang; Harusha Simplice; Samuel E Kalluvya; John M Changalucha; Warren D Johnson; Daniel W Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

2.  [Schistosomiasis in a leiomyoma of the uterus].

Authors:  D Mayr; J Straub; J Müller-Höcker
Journal:  Pathologe       Date:  2005-07       Impact factor: 1.011

3.  Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa.

Authors:  Martial L Ndeffo Mbah; Eyrun F Kjetland; Katherine E Atkins; Eric M Poolman; Evan W Orenstein; Lauren Ancel Meyers; Jeffrey P Townsend; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

4.  Treating cofactors can reverse the expansion of a primary disease epidemic.

Authors:  Lee R Gibson; Bingtuan Li; Susanna K Remold
Journal:  BMC Infect Dis       Date:  2010-08-23       Impact factor: 3.090

Review 5.  Genital manifestations of tropical diseases.

Authors:  J Richens
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

Review 6.  Maternal schistosomiasis: a growing concern in sub-Saharan Africa.

Authors:  Oyetunde T Salawu; Alexander B Odaibo
Journal:  Pathog Glob Health       Date:  2014-09-16       Impact factor: 2.894

7.  A systematic review of handheld tools in lieu of colposcopy for cervical neoplasia and female genital schistosomiasis.

Authors:  Solrun Søfteland; Motshedisi Hannah Sebitloane; Myra Taylor; Borghild Barth Roald; Sigve Holmen; Hashini Nilushika Galappaththi-Arachchige; Svein Gunnar Gundersen; Eyrun Floerecke Kjetland
Journal:  Int J Gynaecol Obstet       Date:  2021-02-12       Impact factor: 3.561

Review 8.  Epidemiology and control of human schistosomiasis in Tanzania.

Authors:  Humphrey D Mazigo; Fred Nuwaha; Safari M Kinung'hi; Domenica Morona; Angela Pinot de Moira; Shona Wilson; Jorg Heukelbach; David W Dunne
Journal:  Parasit Vectors       Date:  2012-11-28       Impact factor: 3.876

9.  S. haematobium as a common cause of genital morbidity in girls: a cross-sectional study of children in South Africa.

Authors:  Ingrid Elise Amlie Hegertun; Kristin Marie Sulheim Gundersen; Elisabeth Kleppa; Siphosenkosi Gift Zulu; Svein Gunnar Gundersen; Myra Taylor; Jane D Kvalsvig; Eyrun Floerecke Kjetland
Journal:  PLoS Negl Trop Dis       Date:  2013-03-21

10.  Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women.

Authors:  H Rafferty; A S Sturt; C R Phiri; E L Webb; M Mudenda; J Mapani; P L A M Corstjens; G J van Dam; A Schaap; H Ayles; R J Hayes; L van Lieshout; I Hansingo; A L Bustinduy
Journal:  BMC Infect Dis       Date:  2021-07-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.